4/A
Changes in Ownership
Korro Bio, Inc. Filed Acc 0000950170-23-032737
President and CEO sold 5,225 shares at an average $0.36 ($1,906)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lucchino David L. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-07 | Sale : show line 1 in the form 10b5-1 | −2,634 | $0.35 | $922 | 718,014 | D |
| 2023-07-10 | Sale : show line 2 in the form 10b5-1 | −2,591 | $0.38 | $985 | 715,423 | D |
| Open-market sales · 5,225 sh · avg $0.36 · $1,906 | ||||||
Loading xslF345X04/ownership.xml…